PERSPECTA

News from every angle

Back to headlines

Galenicum pharmaceutical company surpasses €300 million in revenue

Galenicum, a pharmaceutical company based in Esplugues de Llobregat, has achieved a significant milestone by exceeding €300 million in revenue for the first time. The company's dermatological business notably contributed to this growth, increasing by 69%.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.